BeiGene vs Cellcolabs
BeiGene vs Cellcolabs, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BeiGene is on 64/100 and Cellcolabs on 55/100.
Where each one leads
BeiGene
- our overall score: 64/100 against 55/100
- agent readiness: 50/100 against 40/100
- domain rating: 68/100 against 37/100
- funding raised: $358M against $15.5M
Cellcolabs
Leads on none of the measures we hold for both companies.
At a glance
| Measure | BeiGene | Cellcolabs |
|---|---|---|
| What it is | A global oncology company developing and commercializing innovative cancer treatments. | AI-powered platform for personalized cell therapy development and manufacturing. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2010 | 2021 |
| Headquarters | Cambridge, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | BeiGene | Cellcolabs |
|---|---|---|
| Employees | Not published | 79 |
| Open roles | 100 | Not published |
| Total funding | $358M | $15.5M |
| Latest round | Secondary Offering | Not published |
| Valuation | $15B | Not published |
| LinkedIn followers | Not published | 6,563 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BeiGene | Cellcolabs |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 64/100 | 55/100 |
| Traction | 40/100 | Not published |
| Team | 30/100 | Not published |
| Search visibility | 17/100 | 2/100 |
| Quality | 88/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 68/100 | 37/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BeiGene | Cellcolabs |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Not detected |
| Analytics | Not detected | Google Tag Manager |
BeiGene vs Cellcolabs: common questions
Which is better, BeiGene or Cellcolabs?
On our 0-100 score BeiGene rates higher (64/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do BeiGene and Cellcolabs compare on the numbers?
BeiGene leads on our overall score (64/100 against 55/100), agent readiness (50/100 against 40/100), domain rating (68/100 against 37/100), funding raised ($358M against $15.5M).
Read the full BeiGene review and pricing or the Cellcolabs review and pricing. You can also browse other BeiGene alternatives we track.